Douglas Albrecht, BSN, CCRA
President, Valiscent Clinical, Inc.
Valiscent Clinical, Inc., established in 2006, provides medical device and diagnostic companies with assistance in the development and management of their clinical projects. Clinical trials are conducted to generate the valid scientific evidence necessary to prove that a product is safe and effective; hence our name Valiscent, which is derived from the term Valid Scientific Evidence.
The company’s founder, Douglas Albrecht, BSN, CCRA, has spent his clinical research career working for both large and small medical device and diagnostic companies helping them design, develop and manage their clinical projects leading to a number of successful marketing applications submitted to the FDA, including PMAs and 510(k)s.
The areas of expertise that Valiscent offers are: Clinical Project Development and Management, Clinical Trial Development and Design, Clinical Site/Investigator Qualification and Selection, Clinical Budget Development and Negotiation, Case Report Form Development and Design, Clinical Trial Initiation, Interim Monitoring, Termination/Close-out, Clinical Report Writing, and SOP Development.
